Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47296

Office O'Donoghue Research Bldg., 1122 NE 13th St., Ste. 4417, OKC 73117

Email jamie-miller@ouhsc.edu


Publications & Presentations

<< 1 2 3 4 5 6 > >>
    11. Hintze T D, Miller J L, Neely S, Lim S Y, Gupta N, Johnson P N. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically ill children transitioning from fentanyl -infusions to methadone. Journal of opioid management. 2023; 19 : 43-56

    12. Stephens K, Miller J L, Harkin M, Neely S, Haws L, Johnson P N. Effect of Phytonadione on Correction of Coagulopathy in Pediatric Patients With Septic Shock. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 423-429

    13. Miller J L, Miller M M, Neely S, Medina M. Impact of Transitioning a Senior Seminar Capstone Course to an Intensive Hybrid Course. American journal of pharmaceutical education. 2023; 87 : ajpe8911

    14. Bradford C, Miller J L, Harkin M, Chaaban H, Neely S, Johnson P N. Melatonin Use in Infants Admitted to Intensive Care Units. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2023; 28 : 635-642

    15. Mayes R A, Johnson P N, White B P, Neely S, Chaaban H, Miller J L. Evaluation of Ceftazidime Use in the Neonatal Intensive Care Unit and Association With Cephalosporin-Resistant Gram-Negative Bacteria. The Annals of pharmacotherapy. 2022; 56 : 1325-1332

<< 1 2 3 4 5 6 > >>



Grants

    1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

    2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

    3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

    5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.




Awards and Honors

1 2 >>
                                                                                            1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.  

                                                                                            3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.  

                                                                                            4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.  

                                                                                            5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.  

1 2 >>



Education

                                                                                            1.  Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.  

                                                                                            2.  Degree: BS. Trevecca Nazarene University. Date: 2002.  




Administrative Assignments

                                                

    1. Role: Department Vice-Chair. Scope: Department. Date: 2021.